EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY-NC-ND 4.0

Very low lipoprotein(a) and type 2 diabetes: implications for ongoing clinical trials

Izza Shahid, Harpreet S Bhatia

American Journal of Preventive Cardiology · 2027-01 · 31 · 101793

DOI: 10.1016/j.ajpc.2026.101793 ↗

Kurz gefasst

Editorial in der Zeitschrift American Journal of Preventive Cardiology, 2027-01. Verfasst von Izza Shahid und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Prevention and Wellness, DeBakey Heart and Vascular Center, Houston, TX, USA. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

early version to give early visibility of the article.

Autor:innen und Institutionen

  • Division of Cardiovascular Prevention and Wellness, DeBakey Heart and Vascular Center, Houston, TX, USA.
  • Center for Cardiovascular Computational and Precision Health (C3PH), Houston Methodist, Houston, TX, USA.
  • University of California San Diego Health, La Jolla, CA, USA.

Zitieren

APA

Shahid, I., & Bhatia, H. S. (2027). Very low lipoprotein(a) and type 2 diabetes: implications for ongoing clinical trials. American Journal of Preventive Cardiology, 31, 101793. https://doi.org/10.1016/j.ajpc.2026.101793

Vancouver

Shahid I, Bhatia HS. Very low lipoprotein(a) and type 2 diabetes: implications for ongoing clinical trials. American Journal of Preventive Cardiology. 2027;31:101793. doi:10.1016/j.ajpc.2026.101793

BibTeX
@article{Shahid2027,
  author = {Shahid, Izza and Bhatia, Harpreet S},
  title = {Very low lipoprotein(a) and type 2 diabetes: implications for ongoing clinical trials},
  journal = {American Journal of Preventive Cardiology},
  year = {2027},
  volume = {31},
  pages = {101793},
  doi = {10.1016/j.ajpc.2026.101793}
}
Kostenlos starten →